GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer

J Transl Med. 2023 Aug 13;21(1):542. doi: 10.1186/s12967-023-04415-w.

Jie Mei^#^{1

2}, Yun Cai^#², Guanyu Jiang^#², Zhao He², Ruixin Wang², Chenghu Song², Yuan Wan³, Wenjun Mao⁴

¹ Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214023, China.
² Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214023, China.
³ The Pq Laboratory of BiomeDx/Rx, Department of Biomedical Engineering, Binghamton University, Binghamton, NY, 13902, USA. ywan@binghamton.edu.
⁴ Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214023, China. maowenjun1@njmu.edu.cn.

^# Contributed equally.

No abstract available

Publication types